Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

332.00p
   
  • Change Today:
      6.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.01m
  • Volume: 15,218
  • Market Cap: £332.05m
  • RiskGrade: 125

Oxford Biomedica CEO John Dawson to step down

By Frank Prenesti

Date: Monday 17 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.
Dawson said he would "retire at the appropriate time".

"I believe this is the right time to start the transition to a new leader given the robustness of the senior team and company as a whole, which is undoubtedly stronger than ever before," he said in a statement.

Oxford Biomedica chairman Dr Roch Doliveux said it had started searching for Dawson's replacement to "lead the group through its next phase of growth".



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 332.00p
Change Today 6.50p
% Change 2.00 %
52 Week High 470.00
52 Week Low 166.80
Volume 15,218
Shares Issued 100.01m
Market Cap £332.05m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.76% below the market average27.76% below the market average27.76% below the market average27.76% below the market average27.76% below the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Price Trend
5.28% below the market average5.28% below the market average5.28% below the market average5.28% below the market average5.28% below the market average
28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average
Income Not Available
Growth
52.97% below the market average52.97% below the market average52.97% below the market average52.97% below the market average52.97% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 12-Jun-2024

Time Volume / Share Price
08:34 18 @ 326.10p
08:27 378 @ 326.10p
08:19 5,079 @ 326.00p
08:17 4,000 @ 326.16p
08:15 4,609 @ 326.10p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page